Navigation Links
Free Dog Heart Checks at McAllister Park
Date:9/11/2010

SAN ANTONIO, Sept. 11 /PRNewswire/ -- The Mobile Dog Heart Health Tour is heading south to San Antonio, Texas, for an afternoon of free heart health examinations in San Antonio's McAllister Dog Park. From 3 p.m. to 8 p.m. on September 17, certified veterinary cardiologists will be performing on site heart screenings in a soundproof medical unit, as well as educating owners about canine heart disease.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100911/CG63271 )

(Photo: http://photos.prnewswire.com/prnh/20100911/CG63271 )

Since early 2009, veterinarians on the Mobile Dog Heart Health Tour have checked the hearts of more than 5,000 dogs around the country and found a previously undetected heart murmur in approximately 20 percent of them. In addition to providing free heart health screenings, veterinarians help to educate dog owners about heart disease – a common ailment that is almost as prevalent in dogs as it is in humans.

About 11 percent of the nearly 75 million dogs in the United States have heart disease(1), and that figure increases to as many as 60 percent among aged dogs and certain predisposed breeds(2). Yet, a national survey shows that more than half of dog owners are unaware that their dog may be at risk of heart failure.

"Early diagnosis and treatment of heart disease can significantly prolong and improve the quality of a dog's life," says Dr. Katie Meier a veterinarian with the Mobile Dog Heart Health Tour. "We look forward to educating local dog owners about heart disease in dogs and the treatment options. By emphasizing the importance of annual veterinary examinations and early diagnosis of heart disease, we hope to help more dogs live longer and better lives."

Veterinary specialists will perform the free dog heart screenings from 3:00 p.m. until 8:00 p.m at McAllister Park, located at 13102 Jones Maltsberger Road. The certified veterinary cardiologists use a stethoscope to listen for heart murmurs and other irregular sounds as well as generally assess whether or not the dogs show any signs of heart disease. Veterinarians will also educate dog owners about the most common symptoms of heart disease: reduced willingness to walk or exercise, difficulty breathing, coughing, loss of appetite and weight loss. Dog owners can learn more at www.YourDogsHeart.com.

Mobile Dog Heart Health Tour stop at McAllister ParkWhen:

Friday, September 17, 2010, from 3:00 p.m. – 8:00 p.m.Where:

McAllister Park, San Antonio, Texas
13102 Jones Maltsberger RoadWhy:

To educate dog owners about canine heart diseaseWho:

Veterinary cardiologists will perform free dog heart screeningsAbout Congestive Heart Failure in Dogs

The Mobile Dog Heart Health Tour is designed to educate people about congestive heart failure (CHF) in dogs.

While there is no cure for CHF, clinical study results have shown that dogs with the condition live nearly twice as long and enjoy a higher quality of life when diagnosed and treated during the early stages of heart failure.

About Boehringer Ingelheim Vetmedica, Inc.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2009, Boehringer Ingelheim posted net sales of US $17.7 billion (12.7 billion euro) while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development. For more information, please visit http://us.boehringer-ingelheim.com.

References:

(1.) Buchanan JW. Causes and prevalence of cardiovascular disease. Curr Vet Ther. 1992;XI:646.

(2.) Rush JE. Chronic Valvular Heart Disease in Dogs. Proceedings of the 26th Annual Waltham Diets/OSU Symposium: Small Animal Cardiology, 2002.


'/>"/>
SOURCE YourDogsHeart.com
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmacists May Help Patients Prevent and Detect Heart Disease
2. Biohearts MyoCell Recognized as one of the Breakthrough Developments of 2010
3. Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
4. People at Intermediate Risk of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal
5. Southwest Hospitals MRI Centers Commitment to State-of-the-Art Technology at the Heart of Nearly 20-Year Relationship with MedInformatix RIS
6. American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy
7. HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference
8. Heart Device Manufacturer in Minnesota and Hospitals in Ohio & Kentucky to Pay Nearly $4 Million to Resolve Fraud Allegations
9. Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program.
10. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
11. HeartSine Technologies Supports Living for Zachary Benefit Golf Tournament
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology:
(Date:12/6/2016)... , ... December 06, 2016 , ... "Add realistic flares ... flicker, flash, and flare from clip to clip with high quality 4K lens flare ... 4K Jewel contains 44 lens flares filmed on the RED Dragon. Utilizing the Dragon ...
(Date:12/5/2016)... , ... December 05, 2016 , ... What: Shriners Hospitals ... the North Pole to our patients – using a video monitor and web-enabled camera. ... hospital will transform the Auditorium into a Christmas Wonderland, which is where the video ...
(Date:12/5/2016)... ... December 05, 2016 , ... Edward ... to announce the arrival of the newest Sciton laser in January 2017. The ... use tunable non-ablative and ablative wavelengths for exceptional results. Outperforming more traditional lasers, ...
(Date:12/5/2016)... ... ... For many years, Andrew G. Zubinas has accumulated over 130 ... the Lithuanian language and its poetry inspired him in writing “ Forest ... all aspects of a living, breathing forest where nothing ever stays the same. His ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted from ... Executive® (ISE®) Central Awards. , Awards include the Information Security Executive® of ...
Breaking Medicine News(10 mins):